23.04.2023, 2041 Zeichen

Marinomed: Marinomed Biotech AG achieved istable total revenues of € 11.3 m (2021: € 11.6 m). Cash and cash equivalents increased by 41% to € 8.2 m (2021: € 5.8 m) due to the drawdown of the last tranche of EIB financing and cost-conscious liquidity management. Further investments in Marinomed's future growth path were reflected in the earnings development according to plan. Thus, research and development expenses remained at a high level of € 6.9 m in 2022 (2021: € 7.5 m). The operating result of € -4.9 m was slightly below the prior-year figure of € -4.1 m. Andreas Grassauer, CEO of Marinomed, says: "2022 was another successful year for Marinomed. Although small-cap life science companies like Marinomed were facing increasing pressure in a challenging market environment, we were again able to prove that our Carragelose portfolio is a sustainably growing business. With the Procter & Gamble partnership, we signed one of the most significant deals in the Company's history. Further milestones were the US patent for the Marinosolv technology and the expansion of our Solv4U technology partnerships. This is a solid foundation for achieving operational profitability in the short term and for driving long-term strategic growth projects." 

Andritz: International technology group Andritz and HydrogenPro, a leader in green hydrogen technology and systems, have entered into a partnership to collaborate on scaling up manufacturing and assembly of electrolyzers for the European market. The collaboration will bring together HydrogenPro’s expertise in high-pressure alkaline electrolyzer (AEL) technology with Andritz’s competence in manufacturing and assembly. This non-exclusive partnership will allow Andritz to include HydrogenPro’s technology in its EPC offering of green hydrogen solutions. HydrogenPro, as a fast-growing global green hydrogen technology company, will be able to speed up its technology offering to the European market.

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (19/04/2023)

Christian Drastil: Wiener Börse Plausch

Number One Awards 2025 an AT&S, Do&Co, Erste Group, Morgan Stanley, Palfinger, EAM (Kategorien 1-6 von 12)

Bildnachweis

Aktien auf dem Radar:VIG, Kapsch TrafficCom, UBM, EuroTeleSites AG, Flughafen Wien, Palfinger, ATX, ATX Prime, ATX TR, ATX NTR, Bawag, Andritz, Mayr-Melnhof, Telekom Austria, RBI, voestalpine, SBO, Frequentis, Pierer Mobility, BKS Bank Stamm, Oberbank AG Stamm, Warimpex, Amag, EVN, CPI Europe AG, Lenzing, Österreichische Post, RHI Magnesita, Deutsche Telekom, Allianz, Fresenius.

---